Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence Scores
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms|Breast Cancer|Cancer of the Breast
Interventions: DRUG: Docetaxel with Cytoxan|DRUG: Dexamethasone
Sponsor: Emory University
Collaborators: Sanofi